title: Humanization of excretory pathway in chimeric mice with humanized liver.
abstract: The liver of a chimeric urokinase-type plasminogen activator (uPA)(+/+)/severe combined immunodeficient (SCID) mouse line recently established in Japan could be replaced by more than 80% with human hepatocytes. We previously reported that the chimeric mice with humanized liver could be useful as a human model in studies on drug metabolism and pharmacokinetics. In the present study, the humanization of an excretory pathway was investigated in the chimeric mice. Cefmetazole (CMZ) was used as a probe drug. The CMZ excretions in urine and feces were 81.0 and 5.9% of the dose, respectively, in chimeric mice and were 23.7 and 59.4% of the dose, respectively, in control uPA(-/-)/SCID mice. Because CMZ is mainly excreted in urine in humans, the excretory profile of chimeric mice was demonstrated to be similar to that of humans. In the chimeric mice, the hepatic mRNA expression of human drug transporters could be quantified. On the other hand, the hepatic mRNA expression of mouse drug transporters in the chimeric mice was significantly lower than in the control uPA(-/-)/SCID mice. In conclusion, chimeric mice exhibited a humanized profile of drug excretion, suggesting that this chimeric mouse line would be a useful animal model in excretory studies.
authors.affiliation: Drug Metabolism and Toxicology, Division of Pharmaceutical Sciences, Graduate School of Medical Science, Kanazawa University, Kanazawa, Kakuma-Machi, Kanazawa, Japan.
authors.forename: Hirotoshi
authors.initials: H
authors.lastname: Okumura
authors.forename: Miki
authors.initials: M
authors.lastname: Katoh
authors.forename: Toshiro
authors.initials: T
authors.lastname: Sawada
authors.forename: Miki
authors.initials: M
authors.lastname: Nakajima
authors.forename: Yoshinori
authors.initials: Y
authors.lastname: Soeno
authors.forename: Hikaru
authors.initials: H
authors.lastname: Yabuuchi
authors.forename: Toshihiko
authors.initials: T
authors.lastname: Ikeda
authors.forename: Chise
authors.initials: C
authors.lastname: Tateno
authors.forename: Katsutoshi
authors.initials: K
authors.lastname: Yoshizato
authors.forename: Tsuyoshi
authors.initials: T
authors.lastname: Yokoi
mesh_terms: D018528:ATP-Binding Cassette Transporters / Q000235:genetics / Q000378:metabolism; D000818:Animals; D000900:Anti-Bacterial Agents / Q000493:pharmacokinetics / Q000633:toxicity; D015311:Cefmetazole / Q000493:pharmacokinetics / Q000633:toxicity; D056486:Chemical and Drug Induced Liver Injury / Q000235:genetics / Q000473:pathology; D005243:Feces / Q000737:chemistry; D022781:Hepatocytes / Q000502:physiology*; D006801:Humans; D008099:Liver / Q000166:cytology / Q000502:physiology*; D051379:Mice; D008813:Mice, Inbred ICR; D016513:Mice, SCID; D008822:Mice, Transgenic / Q000502:physiology*; D004364:Pharmaceutical Preparations / Q000378:metabolism*; D012333:RNA, Messenger / Q000096:biosynthesis / Q000235:genetics; D014568:Urokinase-Type Plasminogen Activator / Q000235:genetics
chemical_list: D018528:ATP-Binding Cassette Transporters; D000900:Anti-Bacterial Agents; D004364:Pharmaceutical Preparations; D012333:RNA, Messenger; D015311:Cefmetazole; D014568:Urokinase-Type Plasminogen Activator